Table 1.
Details of prostate cancer patients used in the study
| Information | Total | White | Black |
|---|---|---|---|
| PCa patients no. | 105 | 50 | 55 |
| Age mean ± S.D. (range) | 59.5 ± 5.9 (41.4–72.2) | 60.9 ± 4.9 (50.3–68.6) | 58.2 ± 6.5 (41.4–72.2) |
| BPHa | 35 (33.3%) | 16 (15.2%) | 19 (18.0%) |
| HGPINb | 38 (36.2%) | 21 (20.0%) | 17 (16.2%) |
| Gleason score (≤7) | 54 (51.4%) | 25 (50%) | 29 (52.7%) |
| Gleason score (8–9) | 51 (48.6%) | 25 (50%) | 26 (47.3%) |
| BCRc | 41 (41.9%) | 17 (34%) | 24 (49%) |
a
BPH: Benign prostatic hyperplasia.
b
HGPIN: High-grade prostatic intraepithelial neoplasia.
c
BCR: Biochemical recurrence.